FASLG and cancer: It is highly possible that NK cells or cytotoxic T lymphocytes could target cancer cells through a Fas ligand or TRAIL-mediated necroptosis in response to a lack of MHC1 molecules (for NK cells), which sometimes happens in cancer cells or through the presentation of a cancer-specific antigen (cytotoxic T cells).